DK1503799T3 - Immunogent, monoklonalt antistof - Google Patents
Immunogent, monoklonalt antistofInfo
- Publication number
- DK1503799T3 DK1503799T3 DK03726990.9T DK03726990T DK1503799T3 DK 1503799 T3 DK1503799 T3 DK 1503799T3 DK 03726990 T DK03726990 T DK 03726990T DK 1503799 T3 DK1503799 T3 DK 1503799T3
- Authority
- DK
- Denmark
- Prior art keywords
- monoclonal antibody
- immunogenic monoclonal
- immunogenic
- antibody
- monoclonal
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001166—Adhesion molecules, e.g. NRCAM, EpCAM or cadherins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001169—Tumor associated carbohydrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001169—Tumor associated carbohydrates
- A61K39/001171—Gangliosides, e.g. GM2, GD2 or GD3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00118—Cancer antigens from embryonic or fetal origin
- A61K39/001182—Carcinoembryonic antigen [CEA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
- C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
- C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6056—Antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0074402A AT502293B1 (de) | 2002-05-15 | 2002-05-15 | Immunogener, monoklonaler antikörper |
| PCT/AT2003/000142 WO2003097663A2 (de) | 2002-05-15 | 2003-05-15 | Immunogener, monoklonaler antikörper, der mindestens 2 verschiedene epitope ines tumor-assoziierten antigens aufweist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1503799T3 true DK1503799T3 (da) | 2012-03-19 |
Family
ID=29425358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03726990.9T DK1503799T3 (da) | 2002-05-15 | 2003-05-15 | Immunogent, monoklonalt antistof |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20050181475A1 (da) |
| EP (1) | EP1503799B1 (da) |
| AT (2) | AT502293B1 (da) |
| AU (1) | AU2003232907A1 (da) |
| DK (1) | DK1503799T3 (da) |
| ES (1) | ES2380659T3 (da) |
| WO (1) | WO2003097663A2 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT500650B1 (de) | 2003-04-17 | 2009-11-15 | Altropus Gmbh | Immunogener rekombinanter antikörper |
| AT504160A1 (de) * | 2006-09-11 | 2008-03-15 | Ralf Dr Kircheis | Verwendung einer mehrkomponenten-tumorvakzine |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6010902A (en) * | 1988-04-04 | 2000-01-04 | Bristol-Meyers Squibb Company | Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity |
| CA2123696C (en) * | 1991-11-26 | 2002-07-02 | Lynn E. Spitler | Antitumor vaccines |
| UA40577C2 (uk) * | 1993-08-02 | 2001-08-15 | Мерк Патент Гмбх | Біспецифічна молекула, що використовується для лізису пухлинних клітин, спосіб її одержання, моноклональне антитіло (варіанти), фармацевтичний препарат, фармацевтичний набір (варіанти), спосіб видалення пухлинних клітин |
| EP1658772A3 (en) * | 1995-01-17 | 2007-01-17 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of immunogens |
| WO1997040140A1 (en) * | 1996-04-22 | 1997-10-30 | The Wistar Institute Of Anatomy And Biology | Gd2 anti-idiotypic antibodies and uses thereof |
| US6676946B2 (en) * | 1997-03-27 | 2004-01-13 | Institut Pasteur | Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof |
| PT1230932E (pt) * | 1999-01-13 | 2005-04-29 | Igeneon Krebs Immuntherapie | Uso de anticorpos para vacinacao contra o cancro |
| AU4700100A (en) * | 1999-05-06 | 2000-11-21 | Wake Forest University | Compositions and methods for identifying antigens which elicit an immune response |
| AT409086B (de) * | 1999-11-16 | 2002-05-27 | Igeneon Krebs Immuntherapie | Neue verwendung von antikörpern als impfstoffe |
| DK1267937T3 (da) * | 2000-03-21 | 2009-08-03 | Loibner Hans Dr | Polysaccharid-polypeptid konjugat |
| GB0102145D0 (en) * | 2001-01-26 | 2001-03-14 | Scancell Ltd | Substances |
| BR0209177A (pt) * | 2001-05-03 | 2004-10-05 | Merck Patent Gmbh | Anticorpo especìfico a tumor recombinante e uso do mesmo |
-
2002
- 2002-05-15 AT AT0074402A patent/AT502293B1/de not_active IP Right Cessation
-
2003
- 2003-05-15 AT AT03726990T patent/ATE535259T1/de active
- 2003-05-15 US US10/514,529 patent/US20050181475A1/en not_active Abandoned
- 2003-05-15 EP EP03726990A patent/EP1503799B1/de not_active Expired - Lifetime
- 2003-05-15 WO PCT/AT2003/000142 patent/WO2003097663A2/de not_active Application Discontinuation
- 2003-05-15 ES ES03726990T patent/ES2380659T3/es not_active Expired - Lifetime
- 2003-05-15 AU AU2003232907A patent/AU2003232907A1/en not_active Abandoned
- 2003-05-15 DK DK03726990.9T patent/DK1503799T3/da active
-
2010
- 2010-03-29 US US12/749,456 patent/US20100310551A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003232907A1 (en) | 2003-12-02 |
| EP1503799B1 (de) | 2011-11-30 |
| EP1503799A2 (de) | 2005-02-09 |
| WO2003097663A3 (de) | 2004-03-18 |
| US20050181475A1 (en) | 2005-08-18 |
| WO2003097663A2 (de) | 2003-11-27 |
| AT502293A1 (de) | 2007-02-15 |
| AT502293B1 (de) | 2008-03-15 |
| US20100310551A1 (en) | 2010-12-09 |
| AU2003232907A8 (en) | 2003-12-02 |
| ATE535259T1 (de) | 2011-12-15 |
| ES2380659T3 (es) | 2012-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20044347L (no) | Anti-alfavbeta6-antistoff | |
| DE60222658D1 (de) | Monoklonaler anti-cd-40-antikörper | |
| IS6982A (is) | Mótefni gegn VLA-1 | |
| DK1599504T3 (da) | Modificeret antistof | |
| EE200300179A (et) | Humaniseeritud LT-ß-R-i vastased antikehad | |
| IS2940B (is) | Mótefni gegn CD40 | |
| DK1501856T3 (da) | Anti-HER2 antistofvarianter | |
| NL1027009A1 (nl) | Antilichamen tegen M-CSF. | |
| NO20052149D0 (no) | Vaksine. | |
| DE60305332D1 (de) | IMIDAZOi1,2-AöPYRIDINE | |
| EE200300569A (et) | CD44v6-spetsiifilised antikehad | |
| NO20053363D0 (no) | Malrettede enkle epitoper. | |
| ATE513564T1 (de) | Immunogener rekombinanter antikörper | |
| ITMI20032170A1 (it) | Tagliacimosse. | |
| FI20020807A0 (fi) | Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita | |
| FI20011055A0 (fi) | Heveiiniä sitovat monoklonaaliset vasta-aineet | |
| DK1503799T3 (da) | Immunogent, monoklonalt antistof | |
| DE60239895D1 (de) | Humanisierte super-antikörper | |
| DK1494693T3 (da) | Cripto-specifikke antistoffer | |
| DK1415002T3 (da) | Fokuseret antistofteknologi | |
| ES1052590Y (es) | Quiosco-consigna. | |
| ITMI20020433A1 (it) | Epitopi antigenici di gp100/pme117 | |
| DZ3466A1 (fr) | Station electro-mecano-flu ide. | |
| ES1053097Y (es) | Envase-expositor mejorado. | |
| ES1051703Y (es) | Potera. |